EUVIMEDEUVIMED entdecken
Kohortenstudie

Atopic Dermatitis as a Risk Factor for Herpes Zoster Infection Independent of Treatment: A Nationwide Population-Based Cohort Study

Shou-En Wu, Yi-Hsien Chen, Chi-Hsiang Chung, Gwo-Jang Wu, Chang-Huei Tsao, Chien-An Sun, Wu-Chien Chien, Chih-Tsung Hung iD

Dermatitis® · 01.06.2023 · 34 (3) · 241-249

DOI: 10.1089/derm.2022.0094 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Dermatitis®, online erschienen am 17.05.2023. Verfasst von Shou-En Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Dermatology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Herpes Zoster, Biological Products. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In the wake of the emerging development of biologics in atopic dermatitis (AD), herpes zoster (HZ) infection has been reported as a treatment-related adverse event.

Objectives

This study aims at investigating the association between AD and HZ, and the risk factors within.

Methods

28,677 participants with AD from the Taiwan National Health Insurance Research Database 2000–2015 were enrolled. Risk of HZ infection was compared in the study cohort (with AD) and the control cohort (without AD). Further analyses were conducted in gender-, age-, and treatment strategy-stratified subgroups.

Results

Significantly higher adjusted hazard ratios (aHRs) of HZ infection were revealed in AD patients (aHR = 2.303, P < 0.001), and remained this trend in gender- and age-stratified models. All AD groups, irrespective of the treatment type, had higher aHRs (AD without systemic treatment: aHR = 2.356, P < 0.001; AD with systemic treatment: aHR = 2.182, P < 0.001) compared with those without AD. However, no differences in HZ risk were shown between each treatment type.

Conclusions

Risk of HZ infection in AD is higher irrespective of treatment type. Considering that AD per se increases susceptibility to HZ infection, the administration of biologics requires careful considerations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicHerpes ZosterBiological ProductsHumansCohort StudiesRetrospective StudiesIncidenceRisk Factors

Substanzen

Biological Products

Autor:innen und Institutionen

  • From the Department of Dermatology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
  • School of Public Health, National Defense Medical Center, Taipei, Taiwan.
  • Department of Medical Research, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
  • Taiwanese Injury Prevention and Safety Promotion Association, Taipei, Taiwan.
  • Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan.
  • Department of Obstetrics and Gynecology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.

ORCID-Profile: Chih-Tsung Hung

Zitieren

APA

Wu, S. E., Chen, Y. H., Chung, C. H., Wu, G. J., Tsao, C. H., Sun, C. A., Chien, W. C., & Hung, C. T. (2023). Atopic Dermatitis as a Risk Factor for Herpes Zoster Infection Independent of Treatment: A Nationwide Population-Based Cohort Study. Dermatitis®, 34(3), 241-249. https://doi.org/10.1089/derm.2022.0094

Vancouver

Wu SE, Chen YH, Chung CH, Wu GJ, Tsao CH, Sun CA, et al. Atopic Dermatitis as a Risk Factor for Herpes Zoster Infection Independent of Treatment: A Nationwide Population-Based Cohort Study. Dermatitis®. 2023;34(3):241-249. doi:10.1089/derm.2022.0094

BibTeX
@article{Wu2023,
  author = {Wu, Shou-En and Chen, Yi-Hsien and Chung, Chi-Hsiang and Wu, Gwo-Jang and Tsao, Chang-Huei and Sun, Chien-An and Chien, Wu-Chien and Hung, Chih-Tsung},
  title = {Atopic Dermatitis as a Risk Factor for Herpes Zoster Infection Independent of Treatment: A Nationwide Population-Based Cohort Study},
  journal = {Dermatitis®},
  year = {2023},
  volume = {34},
  number = {3},
  pages = {241--249},
  doi = {10.1089/derm.2022.0094}
}
Kostenlos starten →